E. Ohman J:or Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

E. Ohman J:or Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.01M	Hold	69,612	–	–	0.09%	114
2026 Q1	$4.22M	Sell	69,612 -1,500	-2%	-$87.4K	0.11%	104
2025 Q4	$3.84M	Buy	71,112 +46,000	+183%	+$2.21M	0.09%	111
2025 Q3	$1.13M	Sell	25,112 -1,400	-5%	-$65.4K	0.03%	253
2025 Q2	$1.23M	Hold	26,512	–	–	0.03%	242
2025 Q1	$1.62M	Sell	26,512 -3,488	-12%	-$203K	0.04%	201
2024 Q4	$1.7M	Hold	30,000	–	–	0.04%	195
2024 Q3	$1.55M	Sell	30,000 -5,200	-15%	-$244K	0.04%	195
2024 Q2	$1.46M	Hold	35,200	–	–	0.04%	203
2024 Q1	$1.91M	Hold	35,200	–	–	0.05%	157
2023 Q4	$1.81M	Buy	+35,200	New	+$1.85M	0.07%	143
2023 Q2	–	Sell	-95,800	Closed	-$6.64M	–	424
2023 Q1	$6.64M	Buy	95,800 +4,300	+5%	+$303K	0.26%	62
2022 Q4	$6.58M	Sell	91,500 -1,200	-1%	-$90.5K	0.29%	58
2022 Q3	$6.59M	Sell	92,700 -4,100	-4%	-$297K	0.3%	60
2022 Q2	$7.45M	Sell	96,800 -3,900	-4%	-$297K	0.32%	59
2022 Q1	$7.35M	Sell	100,700 -9,400	-9%	-$631K	0.25%	71
2021 Q4	$6.86M	Buy	110,100 +10,700	+11%	+$628K	0.2%	79
2021 Q3	$5.88M	Buy	99,400 +2,000	+2%	+$132K	0.18%	81
2021 Q2	$6.51M	Buy	97,400 +8,500	+10%	+$554K	0.2%	78
2021 Q1	$5.61M	Buy	88,900 +43,000	+94%	+$2.68M	0.2%	75
2020 Q4	$2.85M	Sell	45,900 -3,600	-7%	-$221K	0.12%	112
2020 Q3	$2.98M	Sell	49,500 -35,900	-42%	-$2.16M	0.15%	86
2020 Q2	$5.02M	Buy	85,400 +1,500	+2%	+$89.7K	0.29%	55
2020 Q1	$4.68M	Sell	83,900 -32,300	-28%	-$1.97M	0.34%	47
2019 Q4	$7.46M	Buy	116,200 +44,300	+62%	+$2.54M	0.41%	42
2019 Q3	$3.65M	Buy	71,900 +3,000	+4%	+$141K	0.23%	66
2019 Q2	$3.12M	Buy	68,900 +2,500	+4%	+$116K	0.21%	67
2019 Q1	$3.17M	Sell	66,400 -350,700	-84%	-$17.5M	0.21%	68
2018 Q4	$21.7M	Buy	417,100 +112,377	+37%	+$6.04M	1.58%	18
2018 Q3	$18.9M	Buy	304,723 +233,923	+330%	+$13.9M	1.22%	22
2018 Q2	$3.92M	Buy	70,800 +23,600	+50%	+$1.27M	0.28%	75
2018 Q1	$2.99M	Sell	47,200 -1,500	-3%	-$96.5K	0.24%	76
2017 Q4	$2.98M	Buy	48,700 +3,600	+8%	+$225K	0.24%	76
2017 Q3	$2.87M	Buy	45,100 +900	+2%	+$52.6K	0.26%	75
2017 Q2	$2.46M	Hold	44,200	–	–	0.25%	72
2017 Q1	$2.4M	Buy	44,200 +4,900	+12%	+$269K	0.29%	67
2016 Q4	$2.3M	Buy	39,300 +3,800	+11%	+$208K	0.32%	64
2016 Q3	$1.91M	Buy	35,500 +3,400	+11%	+$218K	0.28%	74
2016 Q2	$2.36M	Buy	32,100 +1,600	+5%	+$113K	0.39%	61
2016 Q1	$1.95M	Sell	30,500 -2,300	-7%	-$145K	0.35%	65
2015 Q4	$2.26M	Buy	32,800 +2,200	+7%	+$145K	0.4%	61
2015 Q3	$1.81M	Sell	30,600 -4,700	-13%	-$298K	0.49%	47
2015 Q2	$2.35M	Sell	35,300 -2,000	-5%	-$132K	0.55%	46
2015 Q1	$2.41M	Buy	37,300 +2,700	+8%	+$169K	0.56%	44
2014 Q4	$2.05M	Sell	34,600 -2,400	-6%	-$135K	0.49%	44
2014 Q3	$1.89M	Hold	37,000	–	–	0.46%	44
2014 Q2	$1.79M	Sell	37,000 -2,600	-7%	-$128K	0.44%	46
2014 Q1	$2.06M	Sell	39,600 -2,000	-5%	-$106K	0.51%	39
2013 Q4	$2.22M	Sell	41,600 -200	-0.5%	-$10.2K	0.52%	39
2013 Q3	$1.93M	Buy	41,800 +2,300	+6%	+$101K	0.49%	40
2013 Q2	$1.77M	Buy	+39,500	New	+$1.71M	0.49%	37

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

E. Ohman J:or Asset Management's BMY Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 69,612 shares worth $4.01M. The position accounts for 0.09% of the portfolio, ranked #114.

E. Ohman J:or Asset Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $21.7M in Q4 2018. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

E. Ohman J:or Asset Management held 69,612 shares of Bristol-Myers Squibb worth $4.01M as of Q2 2026.
E. Ohman J:or Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.09% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #114 holding.
E. Ohman J:or Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
E. Ohman J:or Asset Management's Bristol-Myers Squibb position peaked at $21.7M in Q4 2018.
878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.